Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Effect of fingolimod on diffuse brain tissue damage in relapsing-remitting multiple sclerosis patients.
Effect of fampridine on axonal excitability in multiple sclerosis.
The autoimmunity-related polymorphism PTPN22 1858C/T is associated with anti-titin antibody-positive myasthenia gravis.
Poster 11 A Rare Case of Chronic Inflammatory Demyelinating Polyneuropathy in the Setting of SLE: A Case Report.
Vascular cognitive impairment neuropathology guidelines (VCING): the contribution of cerebrovascular pathology to cognitive impairment.
Severe tumefactive rebound of multiple sclerosis following fingolimod cessation.
Inositol 1,4,5-trisphosphate receptor type 1 autoantibodies in paraneoplastic and non-paraneoplastic peripheral neuropathy.
Aptamer and its applications in neurodegenerative diseases.
Alterations of Myelin Content in Parkinson's Disease: A Cross-Sectional Neuroimaging Study.
ON THE CONTRIBUTION OF THE PHAGOCYTOSIS AND THE SOLUBILIZATION TO THE IRON OXIDE NANOPARTICLES RETENTION IN AND ELIMINATION FROM LUNGS UNDER LONG-TERM INHALATION EXPOSURE.
Sulthiame as monotherapy in children with benign childhood epilepsy with centrotemporal spikes: a 6-month randomized, double-blind, placebo-controlled study. Sulthiame Study Group.
Geographic population structure in Epstein-Barr Virus revealed by comparative genomics.
Symptomatic treatment in multiple sclerosis-interim analysis of a nationwide registry.
Impact of Demographics, Organ Impairment, Disease, Formulation, and Food on the Pharmacokinetics of the Selective S1P1 Receptor Modulator Ponesimod Based on 13 Clinical Studies.
Integrative network analysis of nineteen brain regions identifies molecular signatures and networks underlying selective regional vulnerability to Alzheimer's disease.
Acute disseminated encephalomyelitis: Updates on an inflammatory CNS syndrome.
A Sensitive and Automatic White Matter Fiber Tracts Model for Longitudinal Analysis of Diffusion Tensor Images in Multiple Sclerosis.
Upper motor neuron evaluation in multiple sclerosis patients treated with Sativex(®).
LINGO-1-Fc-Transduced Neural Stem Cells Are Effective Therapy for Chronic Stage Experimental Autoimmune Encephalomyelitis.
Performance of F2 B6x129 hybrid mice in the Morris water maze, latent inhibition and prepulse inhibition paradigms: Comparison with C57Bl/6J and 129sv inbred mice.
U.S. Medical Eligibility Criteria for Contraceptive Use, 2016.
Modulation of monocytes by bioactive lipid anandamide in multiple sclerosis involves distinct Toll-like receptors.
Neuroinflammatory paradigms in lysosomal storage diseases.
Sensory gating of auditory evoked potentials in rats: effects of repetitive stimulation and the interstimulus interval.
Development of the multiple sclerosis (MS) early mobility impairment questionnaire (EMIQ).
Pages
« first
‹ previous
…
703
704
705
706
707
708
709
710
711
…
next ›
last »